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ABSTRACT The mechanisms underlying the rapidly reversible brain swelling de-
scribed in patients with cerebral malaria (CM) are unknown. Using a 1.5-Tesla (T)
magnetic resonance imaging (MRI) scanner, we undertook an observational study in
Rourkela, India, of 11 Indian patients hospitalized with CM and increased brain vol-
ume. Among the 11 cases, there were 5 adults and 6 children. All patients had re-
duced consciousness and various degrees of cortical swelling at baseline. The latter
was predominately posterior in distribution. The ﬁndings on diffusion-weighted im-
aging (DWI) and apparent diffusion coefﬁcient (ADC) maps were consistent with va-
sogenic edema in all cases. Reversibility after 48 to 72 h was observed in 90% of
cases. DWI/ADC mismatch suggested the additional presence of cytotoxic edema in
the basal nuclei of 5 patients; all of these had perfusion parameters consistent with
vascular engorgement and not with ischemic infarcts. Our results suggest that an
impairment of the blood-brain barrier is responsible for the brain swelling in CM. In
5 cases, vasogenic edema occurred in conjunction with changes in the basal nuclei
consistent with venous congestion, likely to be caused by the sequestration of Plas-
modium falciparum-infected erythrocytes. While both mechanisms have been individ-
ually postulated to play an important role in the development of CM, this is the ﬁrst
demonstration of their concurrent involvement in different parts of the brain. The
clinical and radiological characteristics observed in the majority of our patients are
consistent with posterior reversible encephalopathy syndrome (PRES), and we show
for the ﬁrst time a high frequency of PRES in the context of CM.
IMPORTANCE The pathophysiology and molecular mechanisms underlying cerebral
malaria (CM) are still poorly understood. Recent neuroimaging studies demonstrated
that brain swelling is a common feature in CM and a major contributor to death in
pediatric patients. Consequently, determining the precise mechanisms responsible
for this swelling could open new adjunct therapeutic avenues in CM patients. Using
an MRI scanner with a higher resolution than the ones used in previous reports, we
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identiﬁed two distinct origins of brain swelling in both adult and pediatric patients
from India, occurring in distinct parts of the brain. Our results support the hypothe-
sis that both endothelial dysfunction and microvascular obstruction by Plasmodium
falciparum-infected erythrocytes make independent contributions to the pathogene-
sis of CM, providing opportunities for novel therapeutic interventions.
KEYWORDS MRI, PRES, Plasmodium falciparum, vasogenic edema, cerebral malaria
Plasmodium falciparum malaria is a complex disease with a broad spectrum ofmanifestations. The pathophysiology of cerebral malaria (CM), its most severe form,
is still poorly understood. During the past decade, magnetic resonance imaging (MRI)
facilities have become increasingly accessible in countries where malaria is endemic,
creating new opportunities to investigate the mechanisms underlying the occurrence
of CM in living patients (1).
By allowing the comparison of speciﬁc parameters between CM patients who survive
and those who succumb to the disease, the systematic use of MRI in an extensive study
performed in patients from Malawi demonstrated the importance of increased brain
volume as a major contributor to death in pediatric CM. The cerebral swelling is
transient and quickly reversible with routine treatment in survivors but is associated
with progression to herniation and respiratory arrest in fatal cases (2). This general
mechanism is consistent with the rapid and complete recovery observed in the majority
of surviving cases, and while various hypotheses have been suggested, the cellular
pathogenesis underlying the rapidly reversible coma in CM remains unknown (3–5).
In this study, we performed serial brain scans in 11 patients with CM from India who
presented with increased brain volume on MRI to investigate the pathophysiology of
brain swelling in CM.
RESULTS
Clinical course. During the study period, 27 patients with CM were admitted to
Ispat General Hospital (IGH). Three of the patients died shortly after admission and
treatment and did not undergo MRI; 24 survived (88.8%). Eleven of these patients had
an MRI abnormality at baseline consistent with increased brain volume and were
included in our study. These 11 nonfatal CM cases formed the basis of our analysis
(Fig. 1). There were ﬁve adult and six pediatric patients. The median (range) age was 29
(22 to 40) years for adults and 12 (5 to 15) years for children. There were 4 (80%) adult
and 5 (83.3%) pediatric male cases. All patients were comatose (i.e., Glasgow coma
score [GCS] of 9 of 15 or Blantyre coma score [BCS] of 2 of 5) at baseline. Three of
ﬁve (60%) adults had a GCS of 15 by 72 h, and all were fully recovered by 1 month,
whereas in the pediatric cases, 5/6 (83.3%) had a GCS of 15 by 72 h, and all were fully
recovered by 1 month. Overall, rapid recovery was seen in all 11 patients. Key clinical
features, complications, and retinal ﬁndings are detailed in Table 1. None of the
patients had sickle cells. All patients had complete neurological recovery; there were no
fatalities.
MRI ﬁndings. All 11 cases in our series had generalized swelling (involving 2
lobes); the swelling was marked in 5/11 (45%) patients, moderate in 4/11 (36%), and
mild in 2/11 (18%). All 11 had cortical thickening, which was either unilateral (2/11,
18%) or bilateral (9/11, 81.8%). An increased signal on axial T2-weighted and ﬂuid-
attenuated inversion recovery (T2/FLAIR) was present in all cases during the ﬁrst scan,
and in 8/11 (72.7%) cases, the distribution was posterior, involving the occipital/parietal
and temporal lobes and sparing the frontal lobe (Fig. 2A and B). After 48 to 72 h,
complete or nearly complete resolution of cortical thickening and T2/FLAIR signal was
seen in all the adult cases and 3/6 (50%) pediatric cases (Fig. 2C and D). Among the
latter group, the three remaining patients did not undergo an additional scan but
remained clinically well (Table 1).
(i) Vasogenic and cytotoxic edema. There was evidence of vasogenic edema in all
11 patients scanned (Fig. 3 and 4A and B). The severity of vasogenic edema was variable
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and accounted for the degree of brain swelling described above. In ﬁve patients, there
were patchy areas of diffusion-weighted imaging/apparent diffusion coefﬁcient (DWI/
ADC) mismatch, consistent with ischemia and cytotoxic edema. Cerebral blood volume
(CBV), cerebral blood ﬂow (CBF), and mean transit time (MTT) were also captured, and
the kinetics of perfusion were analyzed on a regional basis. In these patients, the
increased CBV, minimally delayed CBF, and slow MTT were consistent with vascular
engorgement (Fig. 4C to E). In all cases, both features reversed rapidly upon treatment
(Fig. 4F and G).
(ii) PRES. Because of the posterior predominance of the radiological features and
the rapid clinical improvement following antimalarial treatment, we sought to explore
in more detail the features of posterior reversible encephalopathy syndrome (PRES) in
these cases. All had vasogenic edema, and the imaging abnormalities were mostly
posterior, as described above. The changes were predominately cortical in 7/11 (63.7%)
patients and infrequently involved the subcortical regions (4/11, 36.3%). Nine of the 11
(82%) had bilateral changes, while two were strictly unilateral. Many of the features
discussed above are consistent with PRES. However, the presence of vascular engorge-
ment observed in ﬁve patients (cases ID6, ID28, ID60, ID41, and ID46) is not consistent,
and thus, the term PRES-like was used. No patients had high blood pressure or were
taking drugs associated with PRES prior to their admission (Table 1). Two adult patients
had renal impairment.
Malarial retinopathy. Retinal hemorrhages were observed in 5 of the 11 patients
(45%). Three patients had hemorrhages on admission, which were reversible within 48
to 72 h in one patient, stayed unchanged in another patient, and worsened in the third.
Two patients developed retinal hemorrhages 48 to 72 h postadmission. Hemorrhages
were resolved in all patients at follow-up (Table 1). No other features of retinopathy
were observed.
DISCUSSION
In a comprehensive MRI analysis of 11 nonfatal pediatric and adult CM cases with
increased brain volume, we report observations consistent with vasogenic edema,
involving the posterior part of the brain in all cases. Five of these patients had
concomitant MRI signatures of vascular congestion in their basal nuclei, reﬂecting
involvement of the deep venous system and its tributaries. All patients presented
clinical and radiological evidence of rapid reversibility after antimalarial treatment.
Some of the changes we report here are hallmarks of posterior reversible encephalop-
FIG 1 Flowchart of the study. Of the initial 27 patients enrolled in the study, 3 patients died before
undergoing MRI and 24 were scanned. Thirteen patients had no brain swelling and were not included
in the present analysis. Eleven patients had brain swelling and underwent one (n  11) or two (n  3)
additional scans. Patients not included in the study are indicated by an asterisk.
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athy syndrome (PRES) and suggest that pathogenetic mechanisms in CM may induce
PRES or a PRES-like signature on MRI.
The etiology of brain swelling in CM is unknown but likely to be multifactorial. The
microvascular pathology of this neurologic syndrome is unique and mainly caused by
the binding of P. falciparum-infected erythrocytes (IEs) to vascular endothelium, leading
to microvascular obstruction. This phenomenon is called sequestration and is signiﬁ-
cantly and quantitatively linked to premortem coma in CM patients (6). Adhesive forces
causing clumping of parasitized (autoagglutination) and uninfected red cells (roset-
ting), as well as reduced red cell deformability, are thought to obstruct further micro-
circulatory ﬂow. In addition, by their adherence to microvascular beds, IEs also induce
a broad range of both pathogenetic and protective responses, as well as endothelial
activation and signaling. The latter can lead to blood-brain barrier (BBB) leakage, a
process previously described in CM patients with various degrees of severity (7–11).
Here, we report for the ﬁrst time that in CM patients with brain swelling, BBB dysfunc-
tion occurs in mainly posterior areas of the brain, both in adults and children. The
presence and reversibility of retinal hemorrhages in some of our patients did not mirror
their cerebral features on MRI, and additional studies are needed to assess the potential
correlation between cerebral vascular impairment and retinal hemorrhages in a larger
Indian cohort. The local loss of BBB function leads to vasogenic edema, resulting from
the plasma leaking into the brain parenchyma. However, evidence for a generalized
increase in BBB permeability in CM is still debated (9), and the global distribution of
vasogenic edema was only observed in one of our patients. Plugging of microvessels
by IE sequestration (12), platelet accretion (13), ﬁbrin thrombi (14), red blood cells with
reduced deformability (15), rosetting (16), or a combination of the above (17) can
FIG 2 Cases ID32 (left) and ID46 (right). (A, B) Axial T2 images demonstrate a marked cortical thickening
of the entire cortical mantle in both patients, with widespread sulcal effacement in the posterior
temporal parietal and occipital lobes (red arrows). (C, D) Interval axial T2 images showing nearly complete
resolution of the cortical swelling 48 to 72 h postadmission and treatment, with visible sulci (red arrows).
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contribute to parenchymal hypoperfusion, as well as to BBB dysfunction from increas-
ing local hypertension. Augmented ﬁltration pressure at the level of the capillary beds
could overcome the vascular endothelium and tight intercellular junctions of the BBB,
resulting in endothelial dysfunction and surrounding vasogenic edema.
There was evidence of cytotoxic edema (i.e., DWI and ADC mismatch) in 5 of 11
patients, and in this group, the perfusion parameters were more consistent with
vascular engorgement than an ischemic event per se. Vascular engorgement is an
increase in blood volume, which can be caused by arterial vasodilatation or obstruction
of the cerebral veins and venous sinuses (18). The intravascular biomass of sequestered
IEs may explain the microvascular dilatation and engorgement observed in these
patients, thereby contributing to the increase in cerebral volume seen on imaging. This
is in line with the positive correlation between microvascular engorgement and coma
reported in CM (6). The occurrence of vascular engorgement on MRI was mainly seen
in the basal nuclei in our CM cohort. Previous studies showed that these deep and
highly vascularized structures of the brain are prone to lacunar strokes, as their
penetrating arteries are small and branch directly off a larger, high-pressure, heavily
muscled main artery without tapering (19). Such small penetrating arteries may also be
particularly vulnerable to IE sequestration, and the resulting decreased perfusion could
explain the vascular engorgement of the basal nuclei.
Some of the clinical and radiological characteristics observed in our cohort, namely,
the presence of vasogenic edema with posterior presentation and fast reversibility
upon treatment, suggest a PRES-like phenomenon. PRES is a clinicoradiologic disorder
of reversible cortical and/or subcortical brain edema in patients with acute neurological
symptoms (seizures, encephalopathy, visual disturbances, and alterations of conscious-
ness) in the setting of a broad range of disorders, including bacterial infection (20). MRI
correlates typically include vasogenic edema in the cortex, subcortex, and white
FIG 3 Case ID41. Increased DWI signal in the cortex on admission, with posterior predominance (A) and
no mismatch in corresponding ADC image (B), consistent with vasogenic edema (white boxes). Cortical
increase of CBF (C) and CBV (D) with minimal reduction of MTT (E) in the same area.
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matter of the parieto-occipital lobes bilaterally (21); frontal lobe and cerebellar
involvement are less frequent (22). A key element of the diagnosis of PRES is the
reversibility, which is usually associated with a favorable outcome. However, in its
severe form, PRES can be associated with death and disability; posterior fossa
edema causing obstructive hydrocephalus is one of the postulated causes of
persisting sequelae and death (20, 23).
Although the pathogenesis of PRES remains unclear, impaired cerebral autoregula-
tion caused by the presence of hypertension, drugs (e.g., cyclosporine), or bacterial
infections is thought to increase cerebral perfusion, endothelial dysfunction, and
breakdown of the BBB, resulting in vasogenic edema (20). These processes are consis-
tent with the disease mechanisms described in CM, and the high frequency of PRES-like
presentations we report suggests that an endotheliopathy may be contributing to the
pathophysiology of CM in a subset of patients. The predilection for involvement of
posterior circulation territories in PRES is suspected to result from the relatively sparse
sympathetic innervation of the posterior circulation (24). As sympathetic stimulation is
vasoprotective in both hypertensive (25) and endothelial inﬂammatory (26) causes of
PRES, this sympathetic neural network asymmetry would explain why the BBB is more
susceptible to dysfunction caused by IE sequestration and subsequent inﬂammation in
the posterior areas during CM. This anterior/posterior difference may have inﬂuenced
the variability in BBB disruption reported in previous CM histopathology studies,
depending on the areas of postmortem brain sampling.
Our understanding of PRES, both in terms of pathogenesis and phenotype, is still
evolving (20). Malaria has only been reported as a cause of PRES in one isolated case
(27). In the absence of other causes, the underlying etiology of PRES in our series is the
FIG 4 Case ID60. (A to E) Increased DWI signal in the posterior cortex (A, white arrow) with no mismatch in
corresponding ADC image (B, white arrow). DWI and ADC mismatch in the basal ganglia (A and B, orange boxes)
due to vascular engorgement demonstrated by an increased CBV (C), slightly delayed MTT (D), and nearly normal
CBF (E). (F, G) Interval DWI image (F) and corresponding ADC map (G) demonstrating a complete resolution of the
lesions 48 to 72 h postadmission and treatment.
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P. falciparum infection. While acute kidney injury is commonly present in patients with
PRES or severe malaria, this complication was only observed in two patients and cannot
account for the changes observed in the rest of the cohort. Our systematic study of
patients in this setting where malaria is endemic underscores for the ﬁrst time a high
frequency of a PRES-like presentation in CM, affecting both adults and children. While
cortical involvement with posterior predominance on DWI images was described in
some patients from Malawi (2, 28), the lack of ADC maps did not allow the identiﬁcation
of vasogenic edema and, therefore, of PRES. The presence of radiologic signatures of
vasogenic edema alone or in conjunction with vascular engorgement in the majority of
our patients implicates endothelial dysfunction and sequestration of IEs in the patho-
genesis of CM, a theory that was suggested previously (29).
The present study has several limitations. First, it is a small, single-center series of
case studies, and further analyses involving higher patient numbers are warranted.
Second, we selected 11 of 24 patients with CM based on the presence of abnormalities
on MRI, and the mechanisms of coma are likely to be more diverse than described here.
In addition, the patient selection was restricted to clinically stable subjects who were
able to undergo lengthy MRI scans. Consequently, our results are limited to nonfatal
CM, where PRES may correlate with a better outcome. It is plausible that different
pathogenetic processes are involved in fatal cases, which could explain the lack of
beneﬁt from mannitol, an osmotic diuretic that lowers intracranial pressure by absorb-
ing extracellular ﬂuid into brain capillaries, as an adjunctive therapy in CM (10, 30).
Indeed, it is conceivable that ischemic brain injury occurs in fatal cases (31) and
develops secondarily after vasogenic edema. Further studies are under way to inves-
tigate this hypothesis. Third, although our analysis was focused on patients with
changes on baseline MRI, it is possible that the excluded cases may have had subtle
changes. Future investigations should consider this cohort to facilitate risk stratiﬁcation
on prognosis. Finally, without angiographic imaging, we were unable to describe the
involvement of the vasculature.
In conclusion, our results give new insight into the pathophysiology of reversible
brain swelling frequently observed in CM and corroborate the hypotheses suggest-
ing that an impaired BBB and vascular engorgement are contributors to the
increased brain volume seen in CM patients. A better understanding of the disease
mechanisms and risk stratiﬁcation on prognosis may provide guidance toward new
interventions.
MATERIALS AND METHODS
Study site and patients. The study was carried out at Ispat General Hospital (IGH) in Rourkela, in the
state of Odisha, India, from October 2013 to August 2015. All patients satisﬁed a strict deﬁnition of CM
according to the modiﬁed World Health Organization criteria. Consecutive CM patients with coma
(deﬁned as a Glasgow coma score [GCS] of 9 out of 15 for adults and a Blantyre coma score [BCS] of
2 for young children) after correction of hypoglycemia (2.2 mmol/liter) and infected with Plasmodium
falciparum (detected by rapid diagnostic test and conﬁrmed by the presence of asexual forms of the
parasite in a peripheral blood smear) were eligible for inclusion. Patients who were clinically unstable
because of shock (systolic blood pressure of 80 mm Hg with cool extremities) or signs of respiratory
insufﬁciency (respiratory rate above 40/min, nailbed oxygen saturation 90% by pulse oximetry) were
excluded because of the increased risk incurred by being transported to the MRI facilities. Other
exclusion criteria included the presence of coinfection by other plasmodial species detected by either
rapid diagnostic test or peripheral blood smear examination, metallic devices, documented allergies to
MRI contrast media, a diagnosis of meningitis or other causes of encephalopathy, and in female patients,
pregnancy or lactation. Patients whose relatives did not consent to enrollment or who died within 48 h
of admission or regained consciousness before imaging were excluded. Patients with an underlying
bacterial infection were also excluded, on the basis of clinical observations and positive blood, urine, or
cerebrospinal ﬂuid culture.
Due to the lack of direct association between the presence of retinopathies and CM in
low-malaria-transmission settings, retinal changes were documented but not used as a diagnosis
parameter in the present cohort. Tonic-clonic seizures were diagnosed based on stereotypical signs
and recorded.
Ethics statement. Ethical approval was obtained from The Indian Council of Medical Research
(TDR589/2010/ECDII), as well as from the institutional review boards of Ispat General Hospital, New York
University School of Medicine (S12-03016), and the London School of Hygiene and Tropical Medicine.
Because CM patients are comatose, written informed consent was obtained from the families of all
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patients (ﬁve adults and six children) before enrollment in the study. Following our Institutional Review
Board (IRB)-approved clinical protocol, a nurse carefully described the study to the potential participants’
families in Oriya, the local language in the state of Odisha. The IRB-approved consent form was then read
in its entirety to the families before written consent was sought through signature or inked ﬁngerprint.
The nurse in charge of the enrollment and an impartial witness cosigned the form. Patients whose
families declined the enrollment were not included in the study. Patient consent has been archived with
the authors and is available upon request.
Study procedures. On admission, a full medical history and physical examination were conducted
and recorded on a standardized clinical record form. Rapid diagnostic tests for the detection of
Plasmodium falciparum histidine-rich protein II were used for all patients (SD Bioline; Standard Diagnos-
tics, India). Blood samples were collected for complete blood count, parasite count, hemoglobin,
hematocrit, glucose, and biochemistry. Other investigations, including ECG and blood culture, were
performed when clinically indicated (Table 2). Blood gases were monitored frequently in patients
receiving ventilatory support until they recovered.
Retinal examination. To compare potential differences in pathogenetic processes between
retinal and cerebral vasculatures in our cohort of CM cases (32), all patients underwent retinal
examination by direct and indirect ophthalmoscopy within 6 h of admission, and the severity of the
ﬁndings was graded by two ophthalmologists (R. R. Mohanty and S. Joshi) according to published
classiﬁcation criteria (33).
MR imaging. Imaging of the brain was performed using a 1.5-Tesla (T) Siemens Symphony MRI
scanner (Siemens AG, Erlangen, Germany). Scanning was carried out initially within 10 h of admission and
then again between 48 and 72 h after admission. When MRI abnormalities were identiﬁed on the second
interval scan, a third scan was performed at approximately 1 month. The MRI sequences included sagittal
T1-weighted images, axial T2-weighted and ﬂuid-attenuated inversion recovery (T2/FLAIR) turbo spin
echo, susceptibility-weighted imaging (SWI), axial trace diffusion-weighted imaging (DWI) (b values,
indicative of the degree of diffusion weighting applied, of 0, 500, and 1,000 s/mm2), and axial T1 spin
echo (T1-SE) after contrast (529 mg/ml gadobenate dimeglumine [Multihance]; Bracco Diagnostics).
Contrast injection was performed and monitored by automated injector (MedRad Spectris Solaris EP;
Bayer). The pulse sequences included T2, FLAIR, T1, and gradient echo. Apparent diffusion coefﬁcient
(ADC) maps were generated and used to conﬁrm restricted diffusion (34). Perfusion parameters, such as
cerebral blood volume (CBV), cerebral blood ﬂow (CBF), and mean transit time (MTT), were calculated
using previously described techniques (35). From these sequences, we were able to locate and charac-
terize lesions in the brain, describe their physiological features, and identify temporal changes. The
degree of generalized brain swelling was semiquantiﬁed as mild (just discernible), moderate (clearly
evident without mass effect), or marked (extensive with mass effect). Vasogenic edema was deﬁned
radiologically as an increased DWI signal with markedly increased diffusion coefﬁcients compared with
those of normal white matter (36), whereas cytotoxic edema was deﬁned as DWI hyperintensity
associated with decreased diffusion coefﬁcients compared with those of white matter (DWI/ADC
mismatch) (37).
MRI interpretation. Each MRI was interpreted by two radiologists on-site (M. Majhi and P. Panda)
and one experienced radiologist off-site (S. Kampondeni) using NeuroIndia, a searchable database based
on a systematic scoring system of brain MRI interpretation derived from NeuroInterp (38). The MR studies
and data derived for CBV, CBF, and MTT were analyzed blindly by an independent neuroradiologist
off-site (I. W. Turnbull). Discrepant cases were settled by consensus.
Clinical care. All patients were treated with intravenous artesunate (2.4 mg/kg of body weight). The
ﬁrst dose was given immediately after diagnosis and the second and third at 12-h intervals, for a
minimum of 3 doses. Subsequent doses were administered daily. Once the patients were conscious and
able to take medication orally, the treatment was switched to an artemisinin-based combination therapy:
oral artesunate (4 mg/kg of body weight) once daily for 3 days together with a single dose of oral
sulfadoxine-pyrimethamine (25 and 1.25 mg/kg of body weight) on the ﬁrst day of oral therapy. A single
gametocytocidal dose of primaquine (0.75 mg/kg of body weight) was given on the second day of oral
therapy. These treatments were in accordance with the national drug policy of the Government of India.
Disability at discharge or new/progression of symptoms by 1 month were determined and described on
the basis of the Glasgow or Blantyre coma score, retinal changes, and cranial nerve and motor system
function. When possible, a third MRI scan was performed for patients who had magnetic resonance
abnormalities on the second scan.
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